Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 15.09.2020
SNP Schneider-Neureither & Partner SE
Corporate News
SNP's New Move-to-Cloud Solution Moves Microsoft Customers to the Azure Cloud
- Launch of "Cloud Move for Azure" adds a powerful component to the SNP portfolio
- The software enables fast and secure migrations from SAP systems to the cloud and at the same time forms the basis for subsequent data transformations
Heidelberg, Septem [ … ]
Tue, 15.09.2020
DIC Asset AG
Press Release
DIC Asset AG acquires Refurbishment under Cashflow in Stuttgart region
Multi-tenant office building "Gate 9" in Leinfelden-Echterdingen (Stuttgart fairground / airport area) with additional value-add potential during modernisation phase
Pre-let ratio at around 56%, further rental talks ongoing
Completion in the second quarter of 2 [ … ]
Tue, 15.09.2020
Gateway Real Estate AG
DGAP-Media / 15.09.2020 / 07:00
Gateway Real Estate generated EBIT adjusted of EUR 28.4 million in H1 2020
EBIT adjusted rose to EUR 28.4 million in the first half of 2020 (prior-year period: EUR 22.7 million)
Profit after tax amounted to EUR 7.7 million in H1 2020 (prior-year period: EUR 1.8 million) und earnings per share to 0.04 EUR
[ … ]
Tue, 15.09.2020
Newron Pharmaceuticals S.p.A.
Newron announces half-year 2020 results
Milan, Italy, September 15, 2020 - Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational progres [ … ]
Tue, 15.09.2020
Relief Therapeutics Holdings AG
Relief Reports Half-Year 2020 Results
Geneva, Switzerland, September 15, 2020 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100 (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced its results for the half year [ … ]
Tue, 15.09.2020
Leclanché SA
Leclanché provides updates on the strategic Company reorganization announced in June
- Two standalone operating companies, eTransport Solutions and Stationary Storage Solutions, to be carved out and operate under the Leclanché S.A. Group
- Expression of interest by key customers to potentially become strategic shareholders in the large-scale lith [ … ]
Tue, 15.09.2020
YOC AG
YOC with revenue growth in Q3/2020 - further increase in sales because of VIS.X(R) technology platform
Berlin, 15 September 2020 - In the third quarter of 2020, YOC AG (Frankfurt, Prime Standard, ISIN DE0005932735) stopped the downward trend in revenue of the second quarter of 2020 caused by the Corona crisis. According to initial projections, rev [ … ]
Mon, 14.09.2020
Amadeus FiRe AG
Amadeus FiRe AG (ISIN DE0005093108) today concluded a purchase agreement for 100% of the shares in GFN AG, Heidelberg. GFN is a training provider focussing on the market of subsidised adult education and is primarily specialised in IT functions. In 2020 GFN is expected to achieve sales of around 25 million Euros with a neutral operating result. The [ … ]
Mon, 14.09.2020
asknet Solutions AG
asknet Solutionas AG: A ruling by the Federal Court of Finance against asknet solutions AG could result in an obligation for the Company to pay approximately EUR 764,000.00 to the German tax authorities as interest on arrears on already settled VAT claims with respect to previous years
14 September 2020, Karlsruhe (Germany) - The Management Board [ … ]
Mon, 14.09.2020
Adrenomed AG
Data from Adrenomed's AdrenOSS-2 trial with Adrecizumab in Septic Shock to be presented during e-ISICEM
Hennigsdorf/Berlin (Germany), September 14, 2020 - Adrenomed AG, the vascular integrity company, announced today that data from the AdrenOSS-2 Phase II clinical trial with Adrecizumab in septic shock (NCT03085758[1]) will be presented during the [ … ]